Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Metered Dose Inhaler Devices Market From 2025 To 2029?

There has been a robust growth in the market size of metered dose inhaler devices in the past few years. The market value is anticipated to increase from $15.46 billion in 2024 to $16.23 billion in 2025, with a compound annual growth rate (CAGR) of 5.0%. The augmentation in the historic period is as a result of the growing occurrence of diabetes, heightened demand for metered dose inhaler devices, as well as the ascending prevalence of COPD.

Expectations suggest the market size for metered dose inhaler devices is likely to witness significant growth in the upcoming years, surging to a valuation of $20.03 billion by 2029, which represents a compound annual growth rate (CAGR) of 5.4%. This anticipated growth throughout the forecast period can be correlated with the rising frequency of chronic obstructive pulmonary diseases, escalation in asthma cases, growth in infectious disease cases, an increase in diabetes prevalence, and a rise in respiratory disease incidences. The forecast period will likely see several influential trends such as technological developments, exciting therapy breakthroughs, regulatory approvals, the introduction of new inhaler innovations, and the application of online marketing strategies.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

What Are the Major Market Drivers Behind the Rising Adoption of Metered Dose Inhaler Devices Market?

The growth of the metered dose inhaler devices market is expected to be fuelled by the escalating prevalence of chronic obstructive pulmonary diseases. Characterised by airflow obstruction, Chronic obstructive pulmonary disease (COPD) is a steadily advancing lung disease, commonly resulting from prolonged exposure to irritants such as cigarette smoke. It can cause symptoms like shortness of breath, coughing, and wheezing. Factors contributing to the growing incidence of COPD include tobacco use, aging populations, air pollution, and delayed diagnosis or treatment. Metered dose inhaler (MDI) devices provide a direct delivery of medication to the lungs to manage COPD, offering swift relief and enhanced airflow. By December 2023, as per the US-based government agency, the National Institutes of Health, COPD cases are expected to increase from 532 million in 2030 to a staggering 592 million by 2050. Consequently, the escalating prevalence of chronic obstructive pulmonary diseases is stimulating the growth of the metered dose inhaler devices market.

Which Key Market Segments Comprise the Metered Dose Inhaler Devices Market and Drive Its Revenue Growth?

The metered dose inhaler devicesmarket covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=20878&type=smp

Which Areas Are Leading Regions in the Metered Dose Inhaler Devices Market Expansion Across the Globe?

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Strategic Trends Steering theMetered Dose Inhaler Devices Market Direction?

Key players in the metered dose inhaler devices market are concentrating their efforts on the creation of technologically superior products like pressurized metered dose inhalers to optimize drug delivery and increase patient adherence. Pressurized metered-dose inhalers (pMDIs) are inhalation apparatuses that dispense an exact dosage of medication as an aerosol by utilizing pressurized propellant. For example, in July 2023, Lupin Limited, an Indian pharmaceutical firm, introduced Luforbec 100/6 in Germany. This pressurized metered dose inhaler (pMDI) is devised for the treatment of adult asthma and chronic obstructive pulmonary disease (COPD). It combines beclometasone (100 µg) and formoterol (6 µg), making it an efficient solution for patients in need of combination therapy. Remarkably, the pricing for Luforbec is roughly 47% lesser than the established reference price, thereby boosting its reach. Lupin’s decision to launch this product in Germany, a country where almost 5% of adults suffer from asthma, showcases their commitment to tackle essential healthcare concerns and enhance patient results in respiratory treatment.

View the full report here:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

How Is the Metered Dose Inhaler Devices Market Conceptually Defined?

Metered dose inhaler (MDI) devices refer to medical devices designed for delivering precise doses of aerosolized medication directly to the lungs through inhalation. These devices are commonly used in the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other breathing disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model